iBio, Inc.

IBIO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 19, 2026 8-K
4 Oct 15, 2026 OWNERSHIP DOCUMENT
4 Oct 15, 2026 OWNERSHIP DOCUMENT
4 Oct 15, 2026 OWNERSHIP DOCUMENT
4 Oct 15, 2026 OWNERSHIP DOCUMENT
4 Oct 15, 2026 OWNERSHIP DOCUMENT
4 Oct 15, 2026 OWNERSHIP DOCUMENT
SCHEDULE 13G Oct 14, 2026
8-K Oct 13, 2026 8-K
8-K Sep 14, 2026 8-K
ARS Sep 4, 2026 ARS
DEF 14A Sep 4, 2026 DEF 14A
10-K Aug 28, 2026 10-K
8-K Aug 28, 2026 8-K
PRE 14A Aug 20, 2026 PRE 14A
SCHEDULE 13G Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 13, 2026
4 Aug 4, 2026 OWNERSHIP DOCUMENT
3 Aug 4, 2026 OWNERSHIP DOCUMENT
8-K Aug 4, 2026 8-K
8-K Jul 17, 2026 8-K
8-K Jul 1, 2026 8-K
4 May 19, 2026 OWNERSHIP DOCUMENT
← Newer Page 1 of 37 · 909 filings Older →